Modafinil in the treatment of depression with severe comorbid medical illness [2]

Psychosomatics

Volumn 43, Issue 4, 2002, Pages 336-337

  Schwartz, Thomas L ^a   Leso, Laura ^a   Beale, Mark ^a   Ahmed, Rubina ^a   Naprawa, Steven ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; GABAPENTIN; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; MODAFINIL; SERTRALINE; TEMAZEPAM; ZALEPLON;

ANXIETY NEUROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMORBIDITY; DEPRESSION; DRUG EFFECT; HUMAN; LETTER; TREMOR;

EID: 0036638092     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.43.4.336     Document Type: Letter

References (7)

1. Modafinil augmentation of antidepressant treatment in depression
2. Modafinil: A review of its pharmacology and clinical efficacy in the management of narcolepsy
3. Psychostimulant augmentation of second generation antidepressants: A case series
4. Use of stimulants in the medically ill
5. Treatment of a refractory depression with a combination of fluoxetine and damphetamine
6. Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series